GlobalData on MSN3mon
ViiV Healthcare shares results from trial of Dovato and three-drug therapy for HIVUK-based pharmaceutical company ViiV Healthcare has reported results from a trial of Dovato, a two-drug regimen consisting of ...
A specialist HIV company, ViiV Healthcare is majority-owned by GSK while Shionogi and Pfizer are shareholders. "ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisation" was ...
GlaxoSmithKline’s HIV joint venture ViiV Healthcare could mount a challenge ... injected every eight weeks in a formulation that the company hopes will be more appealing than Gilead’s daily ...
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi ...
(RTTNews) - GSK plc (GSK)'s subsidiary ViiV Healthcare, Thursday announced the ... Following this, the company will work with provincial and territorial governments and other stakeholders to ...
ViiV Healthcare and Johnson & Johnson have been ... HIV and more than 100,000 new cases diagnosed every year, and the company said this morning that expanding treatment options is “critical ...
The Navigating HIV video series aims to role model what open and honest conversations between patients and HCPs can look like.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback